Wednesday, April 22, 2026
35 C
Bengaluru

Healthcare Disruption – Will Ola, Swiggy, Pharmaeasy, and Hospitals Converge to Deliver Health Care on Call at Your Doorstep?

Swiggy is working on a marketplace to onboard local stores and direct-to-consumer (D2C) brands and the pilot is already underway.

The platform is called Minis. There are select brands and merchants with whom Swiggy is testing this out.

Morning Dispatch

How long before digital Unicorns like Ola, Swiggy, Pharmeasy, and many others realize the humongous opportunity of delivering health care at the doorstep?

Imagine an app like Ola, where instead of entering where you want to go, you enter the nature of your medical need/emergency and search and find a range of hospitals/doctors/paramedics who can act as the first responders and reach your home in an ambulance or a motorbike with an HCP as a pillion rider with all necessary equipment from the thermometer to defibrillator depending on the nature of the medical care needed and triage and route you/your loved ones to the nearest hospital with an indicative cost of treatment in partnership with health insurance companies?

Healthcare is ripe for disruption, and so is any business where customer dissatisfaction is high.

To understand more about the disruption in healthcare and the future winners and losers, register for MedicinMan Pharma CEO Roundtable and DigiStorm 2022. Write to me at anupsoans@medicinman.net

Write to me at anupsoans@medicinman.net for sponsorship opportunities to network with Healthcare, Pharma, MedTech, Digital-health, DTx, and many other healthcare players.

A Doceree – MedicinMan Thought Leadership Initiative

Hot this week

Precision Farming Market to Witness Promising Growth Opportunities by 2024-2035

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Cytotoxics to Cell Therapy: A 40-Year Review of Indian Oncology Strategy

In 1989, oncology in India was not a business...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

The Healthium Odyssey: From Sutures to Scalpel-Sharp Innovation

The story of Healthium is not just one of...

Topics

Precision Farming Market to Witness Promising Growth Opportunities by 2024-2035

Driven by the ongoing efforts to overcome the inefficiencies...

The Semaglutide Paradox: Anatomy of a High-Stakes Commodity Trap

The Semaglutide Shift: From Blockbuster to Commodity Why the $50...

Ritesh Desai has joined Standard Chartered India as Executive Director

Ritesh Desai has joined Standard Chartered India as Executive...

A Tale of Two Companies – Sun Pharma’s Odyssey and Organon’s Second Act

Sun Pharma’s Odyssey and Organon’s Second Act – And...

The Semaglutide Gold Rush: Miracle Cure or Market Mirage?

The Indian Pharmaceutical Market (IPM) has entered a definitive...
spot_img

Related Articles

spot_imgspot_img